. Pfizer, US ink $5.29B deal for possible COVID-19 treatment « JO LEE MAGAZINE

ABC NEWS – The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators authorize it, the nation’s largest purchase agreement yet for a coronavirus therapy. Pfizer asked the Food and Drug Administration on Tuesday to authorize emergency use of the experimental pill, which has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections. The FDA is already reviewing a competing pill from Merck and will hold a public meeting on it later this month. The price for Pfizer’s potential treatment amounts to about $529 per course.

Therefore at ABC NEWS

World on the Run | Jo Lee Magazine

Comments are closed.